更多...
收起
The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Sep 2008]
[中文简述(自动翻译):]  由该基因编码的蛋白质属于家庭磷脂激酶相关的激酶。这些激酶介导如DNA损伤和营养剥夺应力细胞反应。该蛋白质作为靶的细胞周期停滞和FKBP12雷帕霉素复合物的免疫抑制作用。该ANGPTL7基因位于该基因的内含子。 [由RefSeq的,2008年9月提供]
MTOR基因(以及对应的蛋白质)的细胞分布位置:
MTOR基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Hypertensive disease | 0.2 | 2 | 0 | CTD_human_RGD |
| Schizophrenia | 0.2 | 2 | 0 | CTD_human_RGD |
| Left Ventricular Hypertrophy | 0.2 | 2 | 0 | CTD_human_RGD |
| Liver carcinoma | 0.130606096 | 22 | 0 | BeFree_CTD_human_LHGDN |
| Renal Cell Carcinoma | 0.129781839 | 27 | 0 | BeFree_CTD_human_LHGDN |
| ovarian neoplasm | 0.1254487 | 3 | 0 | CTD_human_LHGDN |
| Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.124895885 | 8 | 0 | BeFree_CTD_human_LHGDN |
| Adenocarcinoma | 0.123538676 | 5 | 0 | BeFree_CTD_human_LHGDN |
| Mesothelioma | 0.122995792 | 2 | 0 | BeFree_CTD_human_LHGDN |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.120814326 | 4 | 0 | BeFree_CTD_human |
| Malformations of Cortical Development | 0.120542884 | 3 | 0 | BeFree_CTD_human |
| FOCAL CORTICAL DYSPLASIA OF TAYLOR | 0.120271442 | 1 | 0 | BeFree_ORPHANET |
| Uterine Cervical Neoplasm | 0.12 | 1 | 0 | CTD_human |
| Neurotoxicity Syndromes | 0.12 | 1 | 0 | CTD_human |
| Carcinoma, Small Cell | 0.12 | 1 | 0 | CTD_human |
| Polycystic Kidney Diseases | 0.083267234 | 4 | 0 | BeFree_LHGDN_RGD |
| Neoplasm Metastasis | 0.083257302 | 13 | 0 | BeFree_RGD |
| Chondrosarcoma | 0.080271442 | 1 | 0 | BeFree_RGD |
| Diabetic Nephropathy | 0.080271442 | 2 | 0 | BeFree_RGD |
| Kidney Failure, Chronic | 0.080271442 | 2 | 0 | BeFree_RGD |
| Muscular Atrophy | 0.080271442 | 2 | 0 | BeFree_RGD |
| Status Epilepticus | 0.080271442 | 3 | 0 | BeFree_RGD |
| Autosomal Recessive Polycystic Kidney Disease | 0.080271442 | 2 | 0 | BeFree_RGD |
| Sepsis | 0.080271442 | 2 | 0 | BeFree_RGD |
| Dementia, Vascular | 0.08 | 1 | 0 | RGD |
| Dyskinesia, Drug-Induced | 0.08 | 1 | 0 | RGD |
| Epilepsy, Temporal Lobe | 0.08 | 1 | 0 | RGD |
| Cardiomegaly | 0.08 | 1 | 0 | RGD |
| Hyperalgesia | 0.08 | 1 | 0 | RGD |
| Hypertension, Portal | 0.08 | 1 | 0 | RGD |
| Pulmonary Hypertension | 0.08 | 1 | 0 | RGD |
| Hypertriglyceridemia | 0.08 | 1 | 0 | RGD |
| Inflammation | 0.08 | 1 | 0 | RGD |
| Liver Cirrhosis, Experimental | 0.08 | 1 | 0 | RGD |
| Mammary Neoplasms, Experimental | 0.08 | 1 | 0 | RGD |
| Myocardial Infarction | 0.08 | 2 | 0 | RGD |
| Pancreatic Neoplasm | 0.08 | 1 | 0 | RGD |
| Shock, Hemorrhagic | 0.08 | 1 | 0 | RGD |
| Temporomandibular Joint Disorders | 0.08 | 1 | 0 | RGD |
| Ureteral obstruction | 0.08 | 1 | 0 | RGD |
| Sciatic Neuropathy | 0.08 | 1 | 0 | RGD |
| Right Ventricular Hypertrophy | 0.08 | 1 | 0 | RGD |
| Infarction, Middle Cerebral Artery | 0.08 | 3 | 0 | RGD |
| Arthritis, Experimental | 0.08 | 1 | 0 | RGD |
| Acute kidney injury | 0.08 | 1 | 0 | RGD |
| Cerebral Hemorrhage | 0.08 | 1 | 0 | RGD |
| Tuberous Sclerosis | 0.020649445 | 58 | 0 | BeFree_LHGDN |
| Mammary Neoplasms | 0.019884777 | 10 | 0 | BeFree_LHGDN |
| Alzheimer's Disease | 0.011354408 | 7 | 0 | BeFree_GAD_LHGDN |
| Prostatic Neoplasms | 0.011168843 | 5 | 0 | BeFree_LHGDN |
| Malignant neoplasm of breast | 0.009229024 | 34 | 0 | BeFree |
| Carcinogenesis | 0.008957582 | 33 | 0 | BeFree |
| Breast Carcinoma | 0.008957582 | 33 | 0 | BeFree |
| Glioblastoma | 0.007077352 | 8 | 0 | BeFree_LHGDN |
| Multiple Myeloma | 0.006253095 | 13 | 0 | BeFree_LHGDN |
| Lung Neoplasms | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Anoxia | 0.0054487 | 2 | 0 | LHGDN |
| melanoma | 0.005167327 | 9 | 1 | BeFree_LHGDN |
| Colorectal Carcinoma | 0.005157396 | 19 | 1 | BeFree |
| Squamous cell carcinoma | 0.004895885 | 9 | 0 | BeFree_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.004885954 | 18 | 0 | BeFree |
| Malignant neoplasm of lung | 0.004810009 | 10 | 0 | BeFree_GAD |
| Colonic Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Rectal Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Colorectal Cancer | 0.004614512 | 17 | 1 | BeFree |
| leukemia | 0.004353001 | 7 | 0 | BeFree_LHGDN |
| Malignant neoplasm of prostate | 0.004071628 | 15 | 0 | BeFree |
| Prostate carcinoma | 0.003800186 | 14 | 0 | BeFree |
| Pancreatic carcinoma | 0.003528744 | 13 | 0 | BeFree |
| Adenoma | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Ameloblastoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Esophageal Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Liver neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Malignant neoplasm of pancreas | 0.002985861 | 11 | 0 | BeFree |
| Autoimmune Diseases | 0.00272435 | 1 | 0 | LHGDN |
| Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Endometriosis | 0.00272435 | 1 | 0 | LHGDN |
| Fetal Growth Retardation | 0.00272435 | 1 | 0 | LHGDN |
| Lymphoproliferative Disorders | 0.00272435 | 1 | 0 | LHGDN |
| Sprains and Strains | 0.00272435 | 1 | 0 | LHGDN |
| Stomach Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Adenocarcinoma, Clear Cell | 0.00272435 | 1 | 0 | LHGDN |
| Alexander Disease | 0.00272435 | 1 | 0 | LHGDN |
| Atrophic | 0.00272435 | 1 | 0 | LHGDN |
| Malignant neoplasm of esophagus | 0.002638474 | 2 | 0 | BeFree_GAD |
| Endometrial Carcinoma | 0.002442977 | 9 | 0 | BeFree |
| Carcinoma of lung | 0.002442977 | 9 | 0 | BeFree |
| Stomach Carcinoma | 0.002442977 | 9 | 1 | BeFree |
| Tobacco Use Disorder | 0.002367032 | 1 | 0 | GAD |
| Malignant neoplasm of endometrium | 0.002171535 | 8 | 0 | BeFree |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.002171535 | 8 | 0 | BeFree |
| Leukemia, Myelocytic, Acute | 0.002171535 | 8 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.002171535 | 8 | 1 | BeFree |
| Ovarian Carcinoma | 0.002171535 | 8 | 0 | BeFree |
| Uterine Corpus Cancer | 0.002171535 | 8 | 0 | BeFree |
| Epilepsy | 0.001900093 | 7 | 0 | BeFree |
| Glioma | 0.001900093 | 7 | 0 | BeFree |
| Lupus Erythematosus, Systemic | 0.001900093 | 7 | 0 | BeFree |
| Obesity | 0.001900093 | 7 | 0 | BeFree |
| Lymphangioleiomyomatosis | 0.001900093 | 7 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.001628651 | 6 | 1 | BeFree |
| Thyroid carcinoma | 0.001628651 | 6 | 1 | BeFree |
| Malignant neoplasm of ovary | 0.001628651 | 6 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 0 | BeFree |
| Brain Neoplasms | 0.001357209 | 5 | 0 | BeFree |
| Rhabdomyosarcoma | 0.001357209 | 5 | 0 | BeFree |
| Seizures | 0.001357209 | 5 | 0 | BeFree |
| Tumor Progression | 0.001357209 | 5 | 0 | BeFree |
| Angiomyolipoma | 0.001357209 | 5 | 0 | BeFree |
| Neuroendocrine Tumors | 0.001357209 | 5 | 0 | BeFree |
| Metastatic Renal Cell Cancer | 0.001357209 | 5 | 0 | BeFree |
| Cortical Dysplasia | 0.001357209 | 5 | 0 | BeFree |
| Hemimegalencephaly | 0.001357209 | 5 | 0 | BeFree |
| Hamartoma | 0.001085767 | 4 | 0 | BeFree |
| Neuroblastoma | 0.001085767 | 4 | 0 | BeFree |
| Thymoma | 0.001085767 | 4 | 0 | BeFree |
| Malignant neoplasm of liver | 0.001085767 | 4 | 0 | BeFree |
| Osteosarcoma of bone | 0.001085767 | 4 | 0 | BeFree |
| Central neuroblastoma | 0.001085767 | 4 | 0 | BeFree |
| Sarcoma | 0.001085767 | 4 | 0 | BeFree |
| Congenital Abnormality | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of urinary bladder | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma, Transitional Cell | 0.000814326 | 3 | 0 | BeFree |
| Malignant tumor of cervix | 0.000814326 | 3 | 0 | BeFree |
| Diabetes | 0.000814326 | 3 | 0 | BeFree |
| Diabetes Mellitus | 0.000814326 | 3 | 0 | BeFree |
| Lupus Vulgaris | 0.000814326 | 3 | 0 | BeFree |
| Lupus Erythematosus, Discoid | 0.000814326 | 3 | 0 | BeFree |
| nervous system disorder | 0.000814326 | 3 | 0 | BeFree |
| Osteosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Peutz-Jeghers Syndrome | 0.000814326 | 3 | 0 | BeFree |
| Pheochromocytoma | 0.000814326 | 3 | 0 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Polycystic Kidney, Autosomal Dominant | 0.000814326 | 3 | 0 | BeFree |
| Benign Neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Congenital anomaly of brain | 0.000814326 | 3 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Cervix carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Lupus Erythematosus | 0.000814326 | 3 | 0 | BeFree |
| Neurodegenerative Disorders | 0.000814326 | 3 | 0 | BeFree |
| Malignant Glioma | 0.000814326 | 3 | 0 | BeFree |
| Refractory cancer | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma of bladder | 0.000814326 | 3 | 0 | BeFree |
| Xenograft Model | 0.000814326 | 3 | 0 | BeFree |
| Chronic Kidney Diseases | 0.000814326 | 3 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000814326 | 3 | 0 | BeFree |
| Urothelial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.000814326 | 3 | 0 | BeFree |
| Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant tumor of colon | 0.000542884 | 2 | 0 | BeFree |
| Hamartoma Syndrome, Multiple | 0.000542884 | 2 | 0 | BeFree |
| Heart Diseases | 0.000542884 | 2 | 0 | BeFree |
| HIV Infections | 0.000542884 | 2 | 0 | BeFree |
| Hypoglycemia | 0.000542884 | 2 | 0 | BeFree |
| Kidney Diseases | 0.000542884 | 2 | 0 | BeFree |
| Myeloid Leukemia, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Waldenstrom Macroglobulinemia | 0.000542884 | 2 | 0 | BeFree |
| Medulloblastoma | 0.000542884 | 2 | 0 | BeFree |
| Meningioma | 0.000542884 | 2 | 0 | BeFree |
| Metabolic Diseases | 0.000542884 | 2 | 0 | BeFree |
| Neurofibromatosis 1 | 0.000542884 | 2 | 0 | BeFree |
| Pituitary Adenoma | 0.000542884 | 2 | 0 | BeFree |
| Unipolar Depression | 0.000542884 | 2 | 0 | BeFree |
| Uterine Fibroids | 0.000542884 | 2 | 0 | BeFree |
| Virus Diseases | 0.000542884 | 2 | 0 | BeFree |
| B-Cell Lymphomas | 0.000542884 | 2 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.000542884 | 2 | 0 | BeFree |
| Cutaneous Melanoma | 0.000542884 | 2 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.000542884 | 2 | 0 | BeFree |
| Esophageal carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Subependymal Giant Cell Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
| Neuroectodermal Tumor, Primitive | 0.000542884 | 2 | 0 | BeFree |
| Gastrointestinal Stromal Tumors | 0.000542884 | 2 | 0 | BeFree |
| Medullary carcinoma of thyroid | 0.000542884 | 2 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000542884 | 2 | 0 | BeFree |
| Vascular Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Hematologic Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Non-alcoholic Fatty Liver Disease | 0.000542884 | 2 | 0 | BeFree |
| Chronic Kidney Insufficiency | 0.000542884 | 2 | 0 | BeFree |
| Recurrent tumor | 0.000542884 | 2 | 0 | BeFree |
| Leukemogenesis | 0.000542884 | 2 | 0 | BeFree |
| Epithelial ovarian cancer | 0.000542884 | 2 | 0 | BeFree |
| Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.000542884 | 2 | 0 | BeFree |
| Colon Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.000542884 | 2 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000542884 | 2 | 0 | BeFree |
| Rhabdoid Tumor of the Kidney | 0.000542884 | 2 | 0 | BeFree |
| Major Depressive Disorder | 0.000542884 | 2 | 0 | BeFree |
| Renal carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Cancer Cell Growth | 0.000542884 | 2 | 0 | BeFree |
| Tumor Angiogenesis | 0.000542884 | 2 | 0 | BeFree |
| Philadelphia chromosome-positive acute lymphoblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
| Promyelocytic leukemia | 0.000542884 | 2 | 0 | BeFree |
| Primary Myelofibrosis | 0.000271442 | 1 | 0 | BeFree |
| Amyotrophic Lateral Sclerosis | 0.000271442 | 1 | 0 | BeFree |
| Asthenia | 0.000271442 | 1 | 0 | BeFree |
| Asthma | 0.000271442 | 1 | 0 | BeFree |
| Autistic Disorder | 0.000271442 | 1 | 0 | BeFree |
| Melanoma, B16 | 0.000271442 | 1 | 0 | BeFree |
| Chordoma | 0.000271442 | 1 | 0 | BeFree |
| Congenital chromosomal disease | 0.000271442 | 1 | 0 | BeFree |
| Adenoid Cystic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
| Dyskinetic syndrome | 0.000271442 | 1 | 0 | BeFree |
| Fanconi Anemia | 0.000271442 | 1 | 0 | BeFree |
| Graves Disease | 0.000271442 | 1 | 0 | BeFree |
| Heart failure | 0.000271442 | 1 | 0 | BeFree |
| Congestive heart failure | 0.000271442 | 1 | 0 | BeFree |
| Hemangioma | 0.000271442 | 1 | 0 | BeFree |
| Hemangiosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis B | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis C | 0.000271442 | 1 | 0 | BeFree |
| Hyperglycemia | 0.000271442 | 1 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory Bowel Diseases | 0.000271442 | 1 | 0 | BeFree |
| insulinoma | 0.000271442 | 1 | 0 | BeFree |
| Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Kidney Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Fibroid Tumor | 0.000271442 | 1 | 0 | BeFree |
| Chronic Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Acute lymphocytic leukemia | 0.000271442 | 1 | 1 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.000271442 | 1 | 1 | BeFree |
| Acute Promyelocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, T-Cell | 0.000271442 | 1 | 0 | BeFree |
| Lipomatosis | 0.000271442 | 1 | 0 | BeFree |
| Lupus Nephritis | 0.000271442 | 1 | 0 | BeFree |
| Lymphocytic Choriomeningitis | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
| Multiple Endocrine Neoplasia Type 1 | 0.000271442 | 1 | 0 | BeFree |
| Nasal Polyps | 0.000271442 | 1 | 0 | BeFree |
| Neurilemmoma | 0.000271442 | 1 | 0 | BeFree |
| Degenerative polyarthritis | 0.000271442 | 1 | 0 | BeFree |
| Pituitary Diseases | 0.000271442 | 1 | 0 | BeFree |
| Pituitary Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| polyps | 0.000271442 | 1 | 0 | BeFree |
| Pruritus | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary Fibrosis | 0.000271442 | 1 | 0 | BeFree |
| Retinoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Septicemia | 0.000271442 | 1 | 0 | BeFree |
| synovial sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Thoracic Outlet Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Thymus Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
| Werner Syndrome | 0.000271442 | 1 | 0 | BeFree |
| AIDS-Associated Nephropathy | 0.000271442 | 1 | 0 | BeFree |
| Immunoblastic Large-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Gestational Diabetes | 0.000271442 | 1 | 0 | BeFree |
| Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
| Small cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Non-arthropod borne lymphocytic choriomeningitis | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of anus | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
| Allergic asthma | 0.000271442 | 1 | 0 | BeFree |
| Agenesis of corpus callosum | 0.000271442 | 1 | 0 | BeFree |
| Ki-1+ Anaplastic Large Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
| Rhabdomyosarcoma, Embryonal | 0.000271442 | 1 | 0 | BeFree |
| Adrenal Cortical Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Hepatocellular Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Follicular thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Acinar Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ganglioglioma | 0.000271442 | 1 | 0 | BeFree |
| Angiofibroma | 0.000271442 | 1 | 0 | BeFree |
| Strawberry nevus of skin | 0.000271442 | 1 | 0 | BeFree |
| Adult Acute Myeloblastic Leukemia | 0.000271442 | 1 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Metastatic malignant neoplasm to brain | 0.000271442 | 1 | 0 | BeFree |
| Malignant ascites | 0.000271442 | 1 | 0 | BeFree |
| Mastocytosis, Systemic | 0.000271442 | 1 | 0 | BeFree |
| Lesion of brain | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of penis | 0.000271442 | 1 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Islet Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
| Laryngomalacia | 0.000271442 | 1 | 0 | BeFree |
| Meckel-Gruber syndrome | 0.000271442 | 1 | 0 | BeFree |
| Pachyonychia Congenita | 0.000271442 | 1 | 0 | BeFree |
| Renal glomerular disease | 0.000271442 | 1 | 0 | BeFree |
| Endometrioma | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of stomach stage IV | 0.000271442 | 1 | 0 | BeFree |
| Stage IV Bladder Cancer AJCC v6 | 0.000271442 | 1 | 0 | BeFree |
| Cancer of Head and Neck | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma Of Esophagus | 0.000271442 | 1 | 0 | BeFree |
| Anal carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cervical Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Multiple polyps | 0.000271442 | 1 | 0 | BeFree |
| Pilocytic Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
| Malonic aciduria | 0.000271442 | 1 | 0 | BeFree |
| Malignant mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Growth Hormone-Secreting Pituitary Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Optic Nerve Glioma | 0.000271442 | 1 | 0 | BeFree |
| Pre B-cell acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary lymphangioleiomyomatosis | 0.000271442 | 1 | 0 | BeFree |
| Trichoepithelioma | 0.000271442 | 1 | 0 | BeFree |
| Lhermitte-Duclos disease | 0.000271442 | 1 | 0 | BeFree |
| Carney Complex | 0.000271442 | 1 | 0 | BeFree |
| Metabolic Syndrome X | 0.000271442 | 1 | 0 | BeFree |
| Myxoid/Round Cell Liposarcoma | 0.000271442 | 1 | 0 | BeFree |
| invasive cancer | 0.000271442 | 1 | 0 | BeFree |
| Dissecting aneurysm of the thoracic aorta | 0.000271442 | 1 | 0 | BeFree |
| Biliary Tract Cancer | 0.000271442 | 1 | 0 | BeFree |
| Mitochondrial Diseases | 0.000271442 | 1 | 0 | BeFree |
| Malignant Squamous Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Malignant Peripheral Nerve Sheath Tumor | 0.000271442 | 1 | 0 | BeFree |
| Parkinsonism, Experimental | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
| Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
| Drug Resistant Epilepsy | 0.000271442 | 1 | 0 | BeFree |
| Collecting Duct Carcinoma of the Kidney | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Perivascular Epithelioid Cell Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Adenoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Kaposiform Hemangioendothelioma | 0.000271442 | 1 | 0 | BeFree |
| Granulosa cell tumor of the ovary | 0.000271442 | 1 | 0 | BeFree |
| Vascular lesions | 0.000271442 | 1 | 0 | BeFree |
| Hepatocarcinogenesis | 0.000271442 | 1 | 0 | BeFree |
| Mammary Tumorigenesis | 0.000271442 | 1 | 0 | BeFree |
| Type II Endometrial Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Macular dystrophy, corneal type 1 | 0.000271442 | 1 | 0 | BeFree |
| FRAGILE X TREMOR/ATAXIA SYNDROME | 0.000271442 | 1 | 0 | BeFree |
| HIP DYSPLASIA, BEUKES TYPE | 0.000271442 | 1 | 0 | BeFree |
| ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED | 0.000271442 | 1 | 0 | BeFree |
| TUBEROUS SCLEROSIS 1 (disorder) | 0.000271442 | 1 | 0 | BeFree |
| TUBEROUS SCLEROSIS 2 (disorder) | 0.000271442 | 1 | 0 | BeFree |
| PTEN Hamartoma Tumor Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.000271442 | 1 | 1 | BeFree |
| Chronic thromboembolic pulmonary hypertension | 0.000271442 | 1 | 0 | BeFree |
| Benign symmetrical lipomatosis | 0.000271442 | 1 | 0 | BeFree |
| Clear-cell metastatic renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 0.000271442 | 1 | 0 | BeFree |
| Plasmablastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Nonmedullary Thyroid Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Meckel syndrome type 1 | 0.000271442 | 1 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Acute-On-Chronic Liver Failure | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。